INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,470,678 | -2.1% | 46,511 | +26.2% | 0.01% | 0.0% |
| Q2 2023 | $1,502,865 | +125347.8% | 36,853 | +14.6% | 0.01% | +20.0% |
| Q1 2023 | $1,198 | +47.0% | 32,149 | +37.6% | 0.01% | +25.0% |
| Q4 2022 | $815 | -100.0% | 23,361 | -23.4% | 0.00% | -55.6% |
| Q3 2022 | $1,705,000 | +46.2% | 30,490 | +35.3% | 0.01% | +50.0% |
| Q2 2022 | $1,166,000 | -26.7% | 22,532 | +2.9% | 0.01% | -25.0% |
| Q1 2022 | $1,590,000 | -10.8% | 21,890 | +45.2% | 0.01% | 0.0% |
| Q4 2021 | $1,782,000 | +289.9% | 15,076 | +342.5% | 0.01% | +300.0% |
| Q3 2021 | $457,000 | +319.3% | 3,407 | +401.0% | 0.00% | +100.0% |
| Q2 2021 | $109,000 | +118.0% | 680 | +8.6% | 0.00% | – |
| Q1 2021 | $50,000 | +150.0% | 626 | +67.8% | 0.00% | – |
| Q4 2020 | $20,000 | +233.3% | 373 | +14.8% | 0.00% | – |
| Q3 2020 | $6,000 | – | 325 | +4542.9% | 0.00% | – |
| Q4 2019 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |